Grace Therapeutics Inc
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol GRCE:xnas
Currency USD
NASDAQ (Small cap)
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Grace Therapeutics Inc
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. Other products are GTx-102 Ataxia-Telangiectasia, GTx-101 Postherpetic Neuralgia, and GTx-201.
Sector Healthcare
Industry Cardiovascular System Biopharmaceuticals
Market Cap 0.041347514bn
Data provided by 
/ 
/ Others were interested in
This information is not currently available for this instrument. Refresh the page or try again later.